25.10.2012
- French drugmaker Sanofi forecast 2012 earnings would fall less than expected as cost cuts and demand for diabetes and rare disease drugs cushion the blow from patent expiries...
25.10.2012
- AstraZeneca's sales slumped 19% in the third quarter, underscoring the scale of the challenge confronting the drugmaker's new chief executive, Pascal Soriot. Faced with patent...
03.10.2012
- Drugmakers Sanofi and Bristol-Myers Squibb plan to revamp their 15-year-old alliance from Jan. 1 in response to lost exclusivity on two key drugs and the arrival of generic...
12.05.2011
- Japan's largest drugmaker Takeda Pharmaceutical is in talks to buy privately-held Swiss rival Nycomed in a deal that could be valued at about $14.2 billion, Bloomberg said, citing...
26.01.2011
- Shifting Priorities - Our world is faced with a growing and aging population. In developed countries, people search for wellness, while in emerging economies, populations seek...
21.01.2011
- Pressures on the U.S. pharmaceutical industry has built over the past few years, stemming from an increasingly stringent drug regulatory environment and the global economic...
17.01.2011
- Outgoing ThyssenKrupp finance chief Alan Hippe will take up the same position at Roche Holding, replacing Erich Hunziker as the Swiss drugmaker implements cost cuts after a series...
